Comprehensive gene analysis for the specimen of pancreatic cancer obtained by EUS-FNA

Comprehensive gene analysis for the specimen of pancreatic cancer obtained by EUS-FNA - Comprehensive gene analysis for the specimen of pancreatic cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030757

Enrollment

Registered

2018-01-20

Start date

2018-01-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

The specimen of pancreatic cancer obtained by EUS-FNA of the first pass is used for this study.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. More than 20 years old 2. Hypovascular pancreatic tumor 3. Necessary of EUS-FNA for diagnosis 4. Performance status with more than 2 5. Without severe complication 6. Acquisition of patients agreement

Exclusion criteria

Exclusion criteria: 1. Presence of interveneous vesseles in the puncture line during EUS-FNA 2. High risk of bleeding 3. Difficulty of performing EUS 4. Without informed consent 5. Deemed ineligible

Design outcomes

Primary

Measure	Time frame
Acquision rate of the specimen obtained by EUS-FNA for comprehensive gene analysis.	—

Countries

Japan

Contacts

Public ContactKen Kamata

Kindai University Faculty of Medicine Department of Gastroenterology and Hepatology

ky11@leto.eonet.ne.jp072-366-0221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026